Analysts Expect AAC Holdings Inc (AAC) to Post $0.06 EPS
Wall Street analysts forecast that AAC Holdings Inc (NYSE:AAC) will report earnings of $0.06 per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for AAC’s earnings, with the highest EPS estimate coming in at $0.25 and the lowest estimate coming in at ($0.13). AAC posted earnings per share of $0.10 during the same quarter last year, which indicates a negative year over year growth rate of 40%. The business is expected to issue its next quarterly earnings report on Wednesday, February 20th.
According to Zacks, analysts expect that AAC will report full year earnings of $0.20 per share for the current year, with EPS estimates ranging from $0.01 to $0.39. For the next financial year, analysts anticipate that the business will post earnings of $0.42 per share, with EPS estimates ranging from ($0.10) to $0.94. Zacks’ earnings per share averages are an average based on a survey of research firms that follow AAC.
AAC (NYSE:AAC) last issued its quarterly earnings results on Tuesday, November 6th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.24 by ($0.32). The business had revenue of $77.47 million for the quarter, compared to analyst estimates of $84.21 million. AAC had a positive return on equity of 4.21% and a negative net margin of 10.20%. The firm’s revenue for the quarter was down 3.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.12 EPS.
Shares of NYSE:AAC opened at $2.03 on Tuesday. The company has a market capitalization of $51.91 million, a P/E ratio of 3.38 and a beta of 1.42. AAC has a fifty-two week low of $1.70 and a fifty-two week high of $12.96. The company has a debt-to-equity ratio of 2.58, a quick ratio of 2.17 and a current ratio of 2.17.
In related news, insider Michael Nanko purchased 21,000 shares of the company’s stock in a transaction on Friday, November 30th. The shares were bought at an average cost of $2.18 per share, for a total transaction of $45,780.00. Following the completion of the purchase, the insider now directly owns 69,700 shares of the company’s stock, valued at approximately $151,946. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Darrell S. Freeman purchased 25,000 shares of the company’s stock in a transaction on Thursday, November 29th. The stock was bought at an average price of $2.19 per share, for a total transaction of $54,750.00. The disclosure for this purchase can be found here. 37.30% of the stock is owned by company insiders.
A number of institutional investors have recently made changes to their positions in AAC. Royce & Associates LP increased its stake in AAC by 446.9% in the third quarter. Royce & Associates LP now owns 978,858 shares of the company’s stock valued at $7,469,000 after purchasing an additional 799,865 shares during the last quarter. Apollo Management Holdings L.P. increased its stake in AAC by 102.9% in the second quarter. Apollo Management Holdings L.P. now owns 466,685 shares of the company’s stock valued at $4,373,000 after purchasing an additional 236,652 shares during the last quarter. BlackRock Inc. increased its stake in AAC by 14.3% in the second quarter. BlackRock Inc. now owns 777,117 shares of the company’s stock valued at $7,282,000 after purchasing an additional 97,361 shares during the last quarter. Mondrian Investment Partners LTD increased its stake in AAC by 22.0% in the third quarter. Mondrian Investment Partners LTD now owns 525,786 shares of the company’s stock valued at $4,012,000 after purchasing an additional 94,649 shares during the last quarter. Finally, Bowling Portfolio Management LLC purchased a new position in AAC in the second quarter valued at approximately $759,000. Institutional investors own 66.22% of the company’s stock.
AAC Company Profile
AAC Holdings, Inc provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC and related companies with MarketBeat.com's FREE daily email newsletter.